SEC Form 4 · accession 0000899243-16-032929
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Andrew Hurley
Officer — Chief Commercial Officer
Period of report
Nov 7, 2016
Accepted (ET)
Nov 8, 2016 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.21 | Nov 7, 2016 | A | 100,000 | A | — | Nov 6, 2026 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1Vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and 2.0833% of the shares vesting monthly thereafter.